XORTX Therapeutics (XRTX) Liabilities and Shareholders Equity (2020 - 2026)
XORTX Therapeutics (XRTX) recorded Liabilities and Shareholders Equity of $6.18 million in the quarter ended Jun 30, 2026, up 125.5% from $2.74 million a year earlier and up 188.3% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
As of Dec 31, 2025, XORTX Therapeutics reported Liabilities and Shareholders Equity of $2.68 million, down 34.5% from the prior year.
- Annual Liabilities and Shareholders Equity has declined for four straight years, though with a five-year compound annual growth rate of 9.4% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $4.09 million in the year ended Dec 31, 2024 (-25.1%), $5.47 million in the year ended Dec 31, 2023 (-57.6%), $12.89 million in the year ended Dec 31, 2022 (-26.7%) and $17.58 million in the year ended Dec 31, 2021 (+928.4%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Liabilities and Shareholders Equity since the quarter ended Sep 30, 2023.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in 1 of the last eight quarters, with an average decline of 15.8%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 895.0% in the quarter ended Dec 31, 2021, against a decline of 55.7% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.14 million (quarter ended Mar 31, 2026), $2.68 million (quarter ended Dec 31, 2025) and $2.81 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | XORTX Therapeutics | 1.60 Mn | -1.70 Mn | - | 6.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.18 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Sep 30, 2023 | 6.64 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 9.66 Mn |
| Dec 31, 2022 | 12.34 Mn |
| Sep 30, 2022 | 11.47 Mn |
| Jun 30, 2022 | 12.59 Mn |
| Mar 31, 2022 | 14.56 Mn |
| Dec 31, 2021 | 17.48 Mn |
| Sep 30, 2021 | 6.22 Mn |
API Access
XORTX Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();